School of Optometry and Vision Science (C.B.H., W.N.), University of Waterloo; Centre for Ocular Research & Education (N.N.), School of Optometry & Vision Science, University of Waterloo; Department of Chemistry (S.K.), University of Waterloo; and Centre for Eye and Vision Research (CEVR) (W.N.), Hong Kong.
Over the past 3 years, the Centre for Ocular Research and Education has received research funding from the following companies: Alcon, Allergan, Allied Innovations, Aurinia Pharma, Azura Pharma, Bausch Health Canada, Brien Holden Vision Institute, CooperVision, GL Chemtec, i-Med Pharma, Johnson & Johnson Vision, Lubris, Menicon, Nature's way, Novartis, Ophtecs, Ote Pharma, PS Therapy, Santen, SightGlass, SightSage, and Visioneering Tech. William Ngo has received consulting fees from Alcon and Sun Pharma. The other authors have no funding or conflicts of interest to disclose.Address correspondence to William Ngo, O.D., Ph.D., School of Optometry & Vision Science University of Waterloo, 200 University Avenue West, Waterloo, ON N2L 3G1, Canada; e-mail: [email protected]
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
